In MEN1, pancreatic neuroendocrine tumors (pNETs) are the second most common neoplasms after parathyroid adenomas, affecting 30-80% of patients, and are a leading cause of MEN1-related mortality [2]. The gene discussed is MEN1; the disease is parathyroid gland adenoma.